Genomics and extreme radiation for recurrent prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how well a very short course of high-dose radiation works for prostate cancer that has come back after surgery. It aims to learn if genetics can help predict who benefits most from this type of radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already part of the 'esSBRT' study at the Regina Elena Cancer Institute.
- You or a legal representative must sign a consent form to join this additional genomics part.
- You cannot have any conditions that would exclude you from the main 'esSBRT' study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a targeted, high-intensity radiation approach given after prostate removal surgery when prostate cancer seems to be coming back locally. It may help control the disease in the pelvis while avoiding treatment that could cause more side effects.
This study tests a very short course of radiation given after prostate surgery, specifically for men whose PSA is rising again. The goal is to see if this approach can safely control the cancer.
This study looks at specific gene changes (TMPRSS2-ERG fusion and PTEN deletion) in people whose prostate cancer returned after radiation. It aims to understand who may have a higher risk of relapse and help predict outcomes after salvage or radical radiation.
This trial compares two types of radiation therapy for prostate cancer that has come back or spread to a few places after surgery. The goal is to see which radiation schedule works better with fewer side effects.
This trial compares two different radiation schedules to treat prostate cancer that returned based on rising PSA blood tests after prostatectomy (prostate removal). If you qualify, it may help you and your team choose a radiation approach with the goal of controlling PSA relapse.
This trial tests a new way of delivering radiation for prostate cancer that has come back after prostate surgery. It may help control the cancer by targeting the “prostate bed” area or nearby lymph nodes where it returned.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.